Skip to main content

Thomas Anthony D'Amico, MD

Gary Hock Distinguished Professor of Surgery
Director, Integrated Thoracic Surgery Residency Program and Joint General Surgery and Thoracic Surgery Residency Program
Director, Advanced Training in Cardiothoracic Surgery
Professor of Surgery
Office: Duke South - 3589 White Zone, Durham, NC 27710
Campus Mail: DUMC Box 3496 Med Ctr, Durham, NC 27710

Lung Cancer

1.Role of molecular markers in the prognosis and therapy of lung cancer
2.Genomic analysis lung cancer mutations

Esophageal Cancer

1.Role of molecular markers in the prognosis and therapy of esophageal cancer
2.Genomic analysis esophageal cancer mutations

Education and Training

  • M.D., Columbia University, 1987


Harpole, D. H., M. B. Moore, J. E. Herndon, T. Aloia, T. A. D’Amico, T. Sporn, A. Parr, I. Linoila, and C. Allegra. “The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.” Clin Cancer Res 7, no. 3 (March 2001): 562–69.


D’Amico, T. A., and D. H. Harpole. “Molecular biology of esophageal cancer.” Chest Surg Clin N Am 10, no. 3 (August 2000): 451–69.


Lau, C. L., S. M. Palmer, K. E. Posther, D. N. Howell, N. L. Reinsmoen, H. T. Massey, V. F. Tapson, J. J. Jaggers, T. A. D’Amico, and R. D. Davis. “Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients.” Ann Thorac Surg 69, no. 5 (May 2000): 1520–24.

Full Text

D’Amico, T. A., T. A. Aloia, M. B. Moore, J. E. Herndon, K. R. Brooks, C. L. Lau, and D. H. Harpole. “Molecular biologic substaging of stage I lung cancer according to gender and histology.” Ann Thorac Surg 69, no. 3 (March 2000): 882–86.

Full Text

Grichnik, K. P., A. J. Ijsselmuiden, T. A. D’Amico, D. H. Harpole, W. D. White, J. A. Blumenthal, and M. F. Newman. “Cognitive decline after major noncardiac operations: a preliminary prospective study.” Ann Thorac Surg 68, no. 5 (November 1999): 1786–91.

Full Text

D’Amico, T. A., M. Massey, J. E. Herndon, M. B. Moore, and D. H. Harpole. “A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.” J Thorac Cardiovasc Surg 117, no. 4 (April 1999): 736–43.

Full Text

Lau, C. L., R. C. Bentley, J. P. Gockerman, L. G. Que, and T. A. D’Amico. “Malignant melanoma presenting as a mediastinal mass.” Ann Thorac Surg 67, no. 3 (March 1999): 851–52.

Full Text